Study to Evaluate the Safety and Preliminary Efficacy of CLL1 and CD38 Dual CAR-T in r/r AML
Clinical trial NCT06110208 · TERMINATED
Trial details
- NCT number
- NCT06110208
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-10
- Primary completion
- 2024-07-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.